Transamerica Financial Advisors’s CVRx CVRX Stock Holding History

Transamerica Financial Advisors’s Portfolio CVRX Stock Details CVRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-11	Closed	-$104	–	2210
2026 Q1	$104	Buy	+11	New	+$80	﹤0.01%	1737

Other funds holding CVRX

Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

GSK plc London $602M AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

SAM

Silvercrest Asset Management New York $15.3B AUM 40.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Transamerica Financial Advisors's CVRX Position: Q2 2026 in Review

Transamerica Financial Advisors sold out of CVRx (CVRX) in Q2 2026, closing a stake of 11 shares — an estimated $104 sold.

Transamerica Financial Advisors first reported a position in CVRX in Q1 2026 and held it in 1 quarter. The position peaked at $104 in Q1 2026. 88 funds tracked by Wall St. Rank hold CVRX as of Q2 2026.

Transamerica Financial Advisors reported no remaining CVRx position as of Q2 2026 after selling out during the quarter.
Transamerica Financial Advisors sold 11 CVRx shares in Q2 2026, an estimated $104.
Transamerica Financial Advisors first reported a position in CVRx in Q1 2026 and held it in 1 quarter.
Transamerica Financial Advisors's CVRx position peaked at $104 in Q1 2026.
88 funds tracked by Wall St. Rank held CVRx as of Q2 2026.

Based on Transamerica Financial Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.